Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein.
Two infectious raccoon poxvirus (RCN) recombinants for expressing rabies virus surface spike glycoprotein (G) were produced by homologous recombination between raccoon poxvirus DNA and chimeric plasmids previously used for production of vaccinia virus recombinants. Expression of G protein was controlled by vaccinia virus promoter P7.5 (early/late class) or by P11 (late class). Immunoprecipitation of infected cell extracts indicated that both of the RCN recombinants directed faithful expression of G protein. Raccoons that were fed polyurethane baits loaded with either recombinant quickly developed high levels of rabies virus neutralizing antibodies and were protected when challenged with lethal raccoon rabies street virus.
Esposito
J J
JJ
Division of Viral Diseases, Centers for Disease Control, Atlanta, Georgia 30333.
Knight
J C
JC
Shaddock
J H
JH
Novembre
F J
FJ
Baer
G M
GM
D000284:Administration, Oral; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D003411:Arvicolinae / Q000276:immunology; D004274:DNA, Recombinant; D004285:Dogs / Q000276:immunology; D012889:Mephitidae / Q000276:immunology; D051379:Mice; D008813:Mice, Inbred ICR / Q000276:immunology; D011212:Poxviridae / Q000276:immunology*; D011817:Rabbits / Q000276:immunology; D011818:Rabies / Q000517:prevention & control / Q000662:veterinary*; D011819:Rabies Vaccines / Q000008:administration & dosage / Q000276:immunology; D011820:Rabies virus / Q000276:immunology*; D011821:Raccoons / Q000276:immunology; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology; D014759:Viral Envelope Proteins / Q000008:administration & dosage / Q000276:immunology*
D000914:Antibodies, Viral; D004274:DNA, Recombinant; D011819:Rabies Vaccines; D014614:Vaccines, Synthetic; D014759:Viral Envelope Proteins